Literature DB >> 33530272

Simultaneous cardio-cerebral infarction in the coronavirus disease pandemic era: A case series.

Rawan Eskandarani1, Seham Sahli, Shaima Sawan, Asim Alsaeed.   

Abstract

INTRODUCTION: Simultaneous occurrence of acute ischemic stroke and myocardial infarction is reported to have variable precipitating causes. This occurrence has been rarely reported in the literature and described only in very few case reports. During the surge of coronavirus disease (COVID-19) in our region, we noted an increase in the simultaneous occurrence of cardio-cerebral infarction. This led us to explore the possible mechanisms and pathophysiology that could contribute to this increase. The retrospective nature of the study limited us from drawing any conclusion about causation. Rather, we aimed to formulate a hypothesis for future, more rigorous studies. PATIENT CONCERNS: We present an overview of 5 cases of simultaneous cardio-cerebral infarction that we encountered in our emergency department within 1 month. DIAGNOSIS: In all cases, diagnosis was confirmed using an electrocardiogram, assessment of laboratory cardiac markers, and imaging.
INTERVENTIONS: In all cases, dual antiplatelet therapy was started and thrombolysis was held, as the condition was considered high risk in most of the patients. Cardiac catheterization lab was not activated either because the patient was unstable or the risk of COVID-19 in staff outweighed the benefit added in patient treatment. OUTCOMES: Two out of 5 patients died because of early complications that lasted for few days. The remaining 3 were discharged from the hospital in moderate functionality for extensive therapy and rehabilitation.
CONCLUSION: Early recognition and immediate treatment is important in different scenarios leading to thrombosis as the outcome. Additionally, addressing the unknown risks that could contribute to our traditional understanding of these causative mechanisms is important. The hypothesis of exacerbated damage caused by inflammatory and immunological endothelial systemic damage should further be explored to be able to delineate new possibilities in managing these conditions.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33530272      PMCID: PMC7850703          DOI: 10.1097/MD.0000000000024496

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  5 in total

Review 1.  Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy.

Authors:  Abdulhamid Abdi; Shahad AlOtaiby; Firas Al Badarin; Ali Khraibi; Hamdan Hamdan; Moni Nader
Journal:  Biomed Pharmacother       Date:  2021-12-09       Impact factor: 7.419

2.  Successful endovascular treatment of simultaneous acute ischaemic stroke and hyperacute ST-elevation myocardial infarction: the first case report of a single-operator cardio-cerebral intervention.

Authors:  Sándor Nardai; András Vorobcsuk; Ferenc Nagy; Zsolt Vajda
Journal:  Eur Heart J Case Rep       Date:  2021-10-14

3.  A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry.

Authors:  Ali Lashkari; Reza Ranjbar
Journal:  J Neurovirol       Date:  2021-09-21       Impact factor: 2.643

4.  Simultaneous acute cardio-cerebral infarction associated with isolated left ventricle non-compaction cardiomyopathy.

Authors:  Ishak Ahmed Abdi; Mesut Karataş; Ahmed Elmi Abdi; Mohamed Sheikh Hassan; Mohamed Farah Yusuf Mohamud
Journal:  Ann Med Surg (Lond)       Date:  2022-07-16

5.  Late Onset Occurrence of Concomitant Myocardial Infarction and Ischemic Stroke in Hospitalized COVID-19 Patient: A Case Report.

Authors:  Antonio Ianniciello; Emilio Attena; Gerardo Carpinella; Ambra Uccello; Ciro Mauro; Vincenzo Russo
Journal:  Int J Gen Med       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.